• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断房颤患者的医疗资源利用情况:来自加菲尔德房颤注册研究的全球分析

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.

作者信息

Mantovani Lorenzo G, Cozzolino Paolo, Ferrara Pietro, Virdone Saverio, Camm A John, Verheugt Freek W A, Bassand Jean-Pierre, Turpie Alexander G G, Hacke Werner, Kayani Gloria, Goldhaber Samuel Z, Goto Shinya, Pieper Karen S, Gersh Bernard J, Fox Keith A A, Haas Sylvia, van Eickels Martin, Kakkar Ajay K

机构信息

Center for Public Health Research, University of Milan-Bicocca, 20900 Monza, Italy.

Laboratory of Public Health, Istituto Auxologico Italiano-IRCCS, 20165 Milan, Italy.

出版信息

Healthcare (Basel). 2023 Feb 21;11(5):638. doi: 10.3390/healthcare11050638.

DOI:10.3390/healthcare11050638
PMID:36900643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10000823/
Abstract

The management of atrial fibrillation (AF), the most common sustained arrhythmia, impacts healthcare resource utilization (HCRU). This study aims to estimate global resource use in AF patients, using the GARFIELD-AF registry. A prospective cohort study was conducted to characterize HCRU in AF patients enrolled in sequential cohorts from 2012 to 2016 in 35 countries. Components of HCRU studied were hospital admissions, outpatient care visits, and diagnostic and interventional procedures occurring during follow-up. AF-related HCRU was reported as the percentage of patients demonstrating at least one event and was quantified as rate-per-patient-per-year (PPPY) over time. A total of 49,574 patients was analyzed, having an overall median follow-up of 719 days. Almost all patients (99.5%) had at least one outpatient care visit, while hospital admissions were the second most frequent medical contact, with similar proportions in North America (37.5%) and Europe (37.2%), and slightly higher in the other GARFIELD-AF countries (42.0%; namely Australia, Egypt, and South Africa). Asia and Latin America showed lower percentages of hospitalizations, outpatient care visits, and diagnostic and interventional procedures. Analyses of GARFIELD-AF highlighted the vast AF-related HCRU, underlying significant geographical differences in the type, quantity, and frequency of AF-related HCRU. These differences were likely attributable to health service availability and differing models of care.

摘要

心房颤动(AF)是最常见的持续性心律失常,其管理会影响医疗资源利用(HCRU)。本研究旨在利用加菲尔德房颤(GARFIELD-AF)注册研究估算房颤患者的全球资源使用情况。进行了一项前瞻性队列研究,以描述2012年至2016年期间在35个国家按序贯队列纳入的房颤患者的HCRU情况。所研究的HCRU组成部分包括住院、门诊就诊以及随访期间发生的诊断和介入程序。房颤相关的HCRU报告为至少出现一次事件的患者百分比,并按每位患者每年的发生率(PPPY)随时间进行量化。共分析了49574例患者,总体中位随访时间为719天。几乎所有患者(99.5%)至少有一次门诊就诊,而住院是第二常见的医疗接触方式,在北美(37.5%)和欧洲(37.2%)比例相似,在其他加菲尔德房颤国家(即澳大利亚、埃及和南非,42.0%)略高。亚洲和拉丁美洲的住院、门诊就诊以及诊断和介入程序的比例较低。加菲尔德房颤研究的分析突出了与房颤相关的巨大HCRU,表明房颤相关HCRU在类型、数量和频率上存在显著的地域差异。这些差异可能归因于卫生服务的可及性和不同的护理模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f8/10000823/63578dcda82b/healthcare-11-00638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f8/10000823/4d45915b3c62/healthcare-11-00638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f8/10000823/63578dcda82b/healthcare-11-00638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f8/10000823/4d45915b3c62/healthcare-11-00638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f8/10000823/63578dcda82b/healthcare-11-00638-g002.jpg

相似文献

1
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.新诊断房颤患者的医疗资源利用情况:来自加菲尔德房颤注册研究的全球分析
Healthcare (Basel). 2023 Feb 21;11(5):638. doi: 10.3390/healthcare11050638.
2
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.法国心房颤动患者的卒中预防、1 年临床结局和医疗资源利用情况:来自 GARFIELD-AF 登记研究的数据。
Arch Cardiovasc Dis. 2018 Dec;111(12):749-757. doi: 10.1016/j.acvd.2018.03.012. Epub 2018 Jun 1.
3
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.印度新诊断房颤患者的风险概况及一年期转归:来自加菲尔德房颤注册研究的见解
Indian Heart J. 2018 Nov-Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.
4
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States.美国新诊断心房颤动患者的医疗资源利用情况。
Expert Rev Pharmacoecon Outcomes Res. 2022 Jul;22(5):763-771. doi: 10.1080/14737167.2022.2045955. Epub 2022 Mar 10.
5
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes.肥胖和糖尿病的非瓣膜性心房颤动患者中利伐沙班与华法林的医疗资源利用及成本比较
Diabetes Ther. 2021 Dec;12(12):3167-3186. doi: 10.1007/s13300-021-01161-4. Epub 2021 Oct 26.
6
Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).为何前瞻性和回顾性登记的患者结局不同?来自 GARFIELD-AF(全球抗凝剂登记研究-房颤)的洞察。
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):27-35. doi: 10.1093/ehjqcco/qcx030.
7
Middle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study.中东地区心房颤动患者的治疗策略与临床结局:加菲尔德房颤研究的一年随访数据
Adv Ther. 2021 May;38(5):2391-2405. doi: 10.1007/s12325-021-01670-5. Epub 2021 Mar 27.
8
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).国际心房颤动卒中风险患者纵向登记研究:FIELD 注册研究(GARFIELD)。
Am Heart J. 2012 Jan;163(1):13-19.e1. doi: 10.1016/j.ahj.2011.09.011. Epub 2011 Nov 20.
9
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.非瓣膜性心房颤动的拉丁美洲国家患者的卒中预防:来自 GARFIELD-AF 注册研究的结果。
Clin Cardiol. 2019 May;42(5):553-560. doi: 10.1002/clc.23176. Epub 2019 Apr 9.
10
Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.波兰及其他欧洲国家心房颤动患者的卒中预防:来自GARFIELD-AF注册研究的见解
Kardiol Pol. 2016;74(4):362-71. doi: 10.5603/KP.a2015.0173. Epub 2015 Sep 14.

引用本文的文献

1
Patient Characteristics and Real-World Treatment of Very Elderly Patients with Nonvalvular Atrial Fibrillation in Japan: An Administrative Claims Database Study.日本非瓣膜性心房颤动高龄患者的患者特征及真实世界治疗:一项行政索赔数据库研究
Cardiol Ther. 2025 Mar;14(1):31-52. doi: 10.1007/s40119-024-00392-3. Epub 2024 Dec 23.

本文引用的文献

1
Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990-2019: results from a global burden of disease study, 2019.全球、区域和国家房颤/房扑疾病负担研究:2019 年全球疾病负担研究结果。
BMC Public Health. 2022 Nov 3;22(1):2015. doi: 10.1186/s12889-022-14403-2.
2
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF.新诊断的心力衰竭合并心房颤动患者的特征、治疗及预后:GARFIELD-AF研究
ESC Heart Fail. 2021 Apr;8(2):1139-1149. doi: 10.1002/ehf2.13156. Epub 2021 Jan 12.
3
Atrial fibrillation in low- and middle-income countries: a narrative review.
低收入和中等收入国家的心房颤动:一篇叙述性综述。
Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O61-O77. doi: 10.1093/eurheartj/suaa181. eCollection 2020 Dec.
4
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs.英国的心房颤动:预测这一新兴流行病的成本 认识和预测与心房颤动相关成本的成本驱动因素。
Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):187-194. doi: 10.1093/ehjqcco/qcaa093.
5
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
6
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.非推荐剂量直接口服抗凝剂治疗的心房颤动患者的死亡率。
J Am Coll Cardiol. 2020 Sep 22;76(12):1425-1436. doi: 10.1016/j.jacc.2020.07.045.
7
The atrial FibriLlatiOn real World management registry in the Middle East and Africa: design and rationale.中东和非洲的心房颤动真实世界管理注册研究:设计与原理。
J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):704-710. doi: 10.2459/JCM.0000000000001007.
8
Drivers of hospitalization in atrial fibrillation: A contemporary review.心房颤动住院治疗的驱动因素:当代综述。
Heart Rhythm. 2020 Nov;17(11):1991-1999. doi: 10.1016/j.hrthm.2020.06.015. Epub 2020 Jun 19.
9
Insights into hospital readmission patterns of atrial fibrillation patients.探讨心房颤动患者的住院再入院模式。
Eur J Cardiovasc Nurs. 2020 Aug;19(6):545-550. doi: 10.1177/1474515120911607. Epub 2020 Mar 9.
10
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.心房颤动的全球流行病学:日益严重的流行趋势及公共卫生挑战。
Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19.